Literature DB >> 26605826

In Vitro Parallel Evaluation of Antibacterial Activity and Cytotoxicity of Commercially Available Silver-Containing Wound Dressings.

Shunji Yunoki1, Masushi Kohta, Yoshimi Ohyabu, Tetsuji Iwasaki.   

Abstract

PURPOSE: This study evaluated the in vitro antibacterial activity and cytotoxicity of various commercially available silver-containing dressings (Ag dressing).
METHODS: Biohesive Ag (hydrocolloid, silver sulfadiazine), Aquacel® Ag (nonwoven fabric, ionic silver [Ag]), Algisite™ Ag (nonwoven fabric, Ag), Mepilex® Ag (foam, silver sulfate), and PolyMem® Ag (foam, nanocrystalline silver) were tested for characteristics of Ag release, antibacterial activity, and cytotoxicity. The release of Ag was investigated in cell culture medium at immersion periods of 6, 24, and 48 hours. The antibacterial activity against Staphylococcus aureus and Pseudomonas aeruginosa were accessed by a disc diffusion test. The cytotoxicity was evaluated using V79 cells, by an extraction method.
RESULTS: The cytotoxicity was not a monotonic function of the antibacterial activity among the Ag dressings and could not be simply explained by Ag-release properties. Biohesive Ag was regarded as a slow-release Ag dressing, showing the lowest cytotoxicity, while the antibacterial activity was classified as "strong" or "significant" against the two species of bacteria. Aquacel Ag and Algisite Ag showed higher antibacterial activity and cytotoxic effects, which were supported by the higher Ag release. Mepilex Ag showed the highest release of Ag, and the cytotoxicity was the highest among the Ag dressings. However, the antibacterial activity was classified as "significant" or "no activity" for P. aeruginosa and S. aureus, respectively. PolyMem Ag showed the lowest Ag release, and the antibacterial activity classified as "significant" or "no activity" for S. aureus and P. aeruginosa, respectively, whereas the cytotoxicity was similar to those of Aquacel Ag and Algisite Ag.
CONCLUSION: The efficacy and adverse effects of the Ag dressings revealed differences that should be considered by clinicians during wound management.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26605826     DOI: 10.1097/PSN.0000000000000096

Source DB:  PubMed          Journal:  Plast Surg Nurs        ISSN: 0741-5206


  7 in total

1.  The Management of Burn Pain in a Pediatric Burns-Specialist Hospital.

Authors:  Kristen Storey; Roy M Kimble; Maleea D Holbert
Journal:  Paediatr Drugs       Date:  2021-01-15       Impact factor: 3.022

2.  Nanocellulose-based wound dressing for conservative wound management in children with second-degree burns.

Authors:  Annika Resch; Clement Staud; Christine Radtke
Journal:  Int Wound J       Date:  2021-01-19       Impact factor: 3.315

3.  Polyvinylpyrrolidone/cellulose acetate electrospun composite nanofibres loaded by glycerine and garlic extract with in vitro antibacterial activity and release behaviour test.

Authors:  Dhewa Edikresnha; Tri Suciati; Muhammad Miftahul Munir; Khairurrijal Khairurrijal
Journal:  RSC Adv       Date:  2019-08-22       Impact factor: 4.036

4.  Superior absorption and retention properties of foam-film silver dressing versus other commercially available silver dressing.

Authors:  Seung Moon Lee; Il Kyu Park; Yong Soo Kim; Hyun Jung Kim; Hanlim Moon; Stefan Mueller; Harsha Arumugam; Young-Il Jeong
Journal:  Biomater Res       Date:  2016-08-06

Review 5.  Advances in Nanotechnology towards Development of Silver Nanoparticle-Based Wound-Healing Agents.

Authors:  Zimkhitha B Nqakala; Nicole R S Sibuyi; Adewale O Fadaka; Mervin Meyer; Martin O Onani; Abram M Madiehe
Journal:  Int J Mol Sci       Date:  2021-10-19       Impact factor: 5.923

6.  Pilot study of minimally adherent silver dressings for acute surgical wounds.

Authors:  Meredyth B Berard; Frank H Lau
Journal:  Health Sci Rep       Date:  2022-10-03

7.  Response of Human Macrophages to Clinically Applied Wound Dressings Loaded With Silver.

Authors:  Patrícia Varela; Lennart Marlinghaus; Susanna Sartori; Richard Viebahn; Jochen Salber; Gianluca Ciardelli
Journal:  Front Bioeng Biotechnol       Date:  2020-02-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.